Critical Appraisals of Cannabis and Related Compounds in Pharmacotherapy.
- Published in:
- Pharmacotherapy, 2020, v. 40, n. 2, p. 100, doi. 10.1002/phar.2365
- By:
- Publication type:
- Article
Works matching IS 02770008 AND DT 2020 AND VI 40 AND IP 2
Results: 12
1
2
Omadacycline Enters the Ring: A New Antimicrobial Contender.
- Published in:
- Pharmacotherapy, 2020, v. 40, n. 2, p. 178, doi. 10.1002/phar.2363
- Publication type:
- Article
3
Drug Interaction Between Febuxostat and Thiopurine Antimetabolites: A Review of the FDA Adverse Event Reporting System and Medical Literature.
- Published in:
- Pharmacotherapy, 2020, v. 40, n. 2, p. 125, doi. 10.1002/phar.2362
- By:
- Publication type:
- Article
4
Successful Long‐term Anticoagulation with Enoxaparin in a Patient with a Mechanical Heart Valve.
- Published in:
- Pharmacotherapy, 2020, v. 40, n. 2, p. 174, doi. 10.1002/phar.2361
- By:
- Publication type:
- Article
5
Potential Clinical Relevance of Differences in Allele Frequencies Found within Very Important Pharmacogenes between Hmong and East Asian Populations.
- Published in:
- Pharmacotherapy, 2020, v. 40, n. 2, p. 142, doi. 10.1002/phar.2360
- By:
- Publication type:
- Article
6
Association Between Hemoglobin A1c and Major Adverse Coronary Events in Patients with Diabetes Following Coronary Artery Bypass Surgery.
- Published in:
- Pharmacotherapy, 2020, v. 40, n. 2, p. 116, doi. 10.1002/phar.2359
- By:
- Publication type:
- Article
7
Bacteriophage Therapeutics: A Primer for Clinicians on Phage‐Antibiotic Combinations.
- Published in:
- Pharmacotherapy, 2020, v. 40, n. 2, p. 153, doi. 10.1002/phar.2358
- By:
- Publication type:
- Article
8
Microbes as Drugs: The Potential of Pharmabiotics.
- Published in:
- Pharmacotherapy, 2020, v. 40, n. 2, p. 102, doi. 10.1002/phar.2357
- By:
- Publication type:
- Article
9
Use of Tissue Plasminogen Activator Alteplase for Suspected Impella Thrombosis.
- Published in:
- Pharmacotherapy, 2020, v. 40, n. 2, p. 169, doi. 10.1002/phar.2356
- By:
- Publication type:
- Article
10
Prevalence of Cardiac Risk Factors in Patients Prescribed Azithromycin before and after the 2012 FDA Warning on the Risk of Potentially Fatal Heart Rhythms.
- Published in:
- Pharmacotherapy, 2020, v. 40, n. 2, p. 107, doi. 10.1002/phar.2355
- By:
- Publication type:
- Article
11
New and Worsening Long‐term Immune‐Related Adverse Events with PD‐1/PD‐L1 Pathway Agents in Patients with Cancer.
- Published in:
- Pharmacotherapy, 2020, v. 40, n. 2, p. 133, doi. 10.1002/phar.2354
- By:
- Publication type:
- Article
12
Issue Information.
- Published in:
- Pharmacotherapy, 2020, v. 40, n. 2, p. 97, doi. 10.1002/phar.2248
- Publication type:
- Article